ArticleCureus2025
Exploring Etiological Risk Factors and Their Association With Epistaxis: A Cross-Sectional Study on 500 Patients in a Tertiary Care Centre in India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction The clinical presentations of epistaxis share a wide spectrum, ranging from minor, self-limiting bleeds to life-threatening hemorrhages, which often require immediate intervention. Our cross-sectional study was conducted to bridge that gap in this direction, focusing on the determination of possible risk factors associated with epistaxis, which undertakes a comprehensive analysis of 500 cases of it in a tertiary care centre in India. Materials and methods A total of 500 patients with epistaxis were analyzed for their risk factor association using SPSS software version 27 (IBM Inc., Armonk, New York). Results We observed the highest association of epistaxis with hypertension (42.8%), and we also found that males share a higher frequency (62.4%) of hypertension as compared to females. Conclusion We conclude by establishing that hypertension, nasal trauma, and anatomical anomalies such as deviated nasal septum (DNS) are the primary independent predictors for epistaxis and recommend targeted preventive and therapeutic strategies to reduce morbidity and recurrence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.